242 related articles for article (PubMed ID: 21344388)
1. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
3. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
4. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Zhang HS; Wu MR
Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways.
Leghmari K; Bennasser Y; Bahraoui E
Eur J Cell Biol; 2008 Dec; 87(12):947-62. PubMed ID: 18760861
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Zhang HS; Sang WW; Wang YO; Liu W
J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
9. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
Jiang MC; Lin JK; Chen SS
Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
[TBL] [Abstract][Full Text] [Related]
11. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
15. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
Zhang HS; Wu TC; Sang WW; Ruan Z
Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
20. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]